Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Major Depressive Disorder
Interventions: Omega-3 fatty acid, Bovine gelatin capsules; Dietary Supplement · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Parenteral Nutrition Associated Liver Disease
Interventions: Lovaza (fish oil); Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 1 Day to 1 Year
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Autistic Disorder
Interventions: B12, Placebo, folate, B complex, vitamin C, cod liver oil, Mineral complex, carnitine; Dietary Supplement
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 3 Years to 7 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Non Familial Chylocmicronemia Syndrome (Non-FCS)
Interventions: LCQ908, Fenofibrate, Fish Oil, Placebo of LCQ908, Placebo of fenofibrate, Placebo of fish oil; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 28
States / cities: Muscle Shoals, Alabama • Glendale, Arizona • Encinitas, California + 23 more

Conditions: Breast Cancer
Interventions: Omega-3 Fatty Acids, Placebo Capsule, Diet and Exercise; Dietary Supplement · Other
Lead sponsor: Carol Fabian, MD; Other
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cholestasis, Liver Diseases
Interventions: Omegaven; Drug
Lead sponsor: Catherine Cibulskis, MD; Other
Eligibility: Up to 1 Year
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Aging, Age-Related Macular Degeneration
Interventions: ZeaVision EyePromise Restore, Multivitamin; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 60 Years to 80 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Depressive Disorder, Major
Interventions: Omega 3 Fatty Acids, Corn oil; Drug · Dietary Supplement
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 12 Years to 19 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Psoriasis
Interventions: Mediterranean Diet; Behavioral
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 94 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Breast Cancer
Interventions: Lovaza 4gm oral, Raloxifene 60 Mg Oral Tablet, Raloxifene 30 Mg Oral Tablet, Lovaza 4gm & Raloxifene 30mg; Dietary Supplement · Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 35 Years to 70 Years · Female only
Enrollment: 266 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Eye Health, Vision, Cognitive Function
Interventions: VisionPure Dietary Supplement, Placebo; Dietary Supplement
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Lutz, Florida • Tampa, Florida

Conditions: Diabetes Mellitus, Type 2
Interventions: Carbohydrate-restricted diet, Mindfulness; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Omega-3 Fatty Acids, Pediatric Bipolar Disorder, Adolescent Bipolar Disorder, Magnetic Resonance Spectroscopy Imaging
Interventions: Omega-3 Fatty Acid, Placebo; Dietary Supplement · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 18 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Infertility, Female, Obesity
Interventions: Microdialysis, Vascepa - Fish Oil, Aspirin, Pioglitazone; Other · Dietary Supplement · Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hot Flashes, Menopause, Vasomotor Symptoms
Interventions: Placebo, Omega-3, Yoga, Exercise, Usual Activity; Dietary Supplement · Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 40 Years to 62 Years · Female only
Enrollment: 355 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Oakland, California • Indianapolis, Indiana • Seattle, Washington

Conditions: Healthy
Interventions: Placebo supplement, Citicoline and Omega-3 supplement, Omega-3 supplement; Dietary Supplement
Lead sponsor: Kyowa Hakko Bio Co., Ltd.; Industry
Eligibility: 55 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Alcohol Dependence
Interventions: Fish Oil with ethanol and placebo ethanol infusions, Placebo with ethanol and placebo ethanol infusions; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 55 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Fatty Acids, Omega-3, Fish Oils
Interventions: VLCPUFA-rich fish oil, DHA-rich fish oil; Dietary Supplement
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Concussion, Mild Traumatic Brain Injury
Interventions: Docosahexaenoic acid (DHA), Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 14 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Asthma, Exercise-Induced Bronchoconstriction
Interventions: Lyprinol, Placebo (Olive Oil); Dietary Supplement
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Type 2 Diabetes, Coronary Artery Disease
Interventions: Icosapent ethyl; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 30 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognitive Decline
Interventions: vitamin D3, omega-3 fatty acids (fish oil), Vitamin D3 placebo, Fish oil placebo; Dietary Supplement · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 60 Years to 92 Years
Enrollment: 3,424 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: Fish Oil Supplementation, Placebo Supplementation; Drug
Lead sponsor: Columbia University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Blood Glucose, High
Interventions: Micronutrient-dense plant-rich Intervention; Behavioral
Lead sponsor: Northern Arizona University; Other
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Flagstaff, Arizona

Search by objective public record fields.

Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response

Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation

Treating Oxidative Stress and the Metabolic Pathology of Autism

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease

Investigation of Macular Pigment Augmentation on Dark Adaptation

The Role Of Omega-3 Fatty Acids In Adolescent Depression

Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

The Effects of VisionPure™ on Indices of Vision Health and Cognitive Function

Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger

Omega 3 Fatty Acid Trial

Mediators of Abnormal Reproductive Function in Obesity (MARO)

MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation

The Combination Effect of Citicoline and Omega-3

Fish Oil vs. Placebo on Subjective Effects of Alcohol

Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals

DHA For The Treatment of Pediatric Concussion Related to Sports Injury

Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline

Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study

A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans